REVEAL GENOMICS, S.L.

REVEAL GENOMICS®´ BREAKTHROUGH TECHNOLOGY ENTERS THE LIQUID BIOPSY FIELD IN ONCOLOGY - Barcelona, Spain (ots/PRNewswire) – – REVEAL GENOMICS®´ machine learning-based technology applied to ctDNA was able to predict drug response and survival outcome in patients with metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitors. – This new approach provides multi-feature genomic predictors from ctDNA for breast cancer and other types of cancer. – The […]
Presseportal